Cancer Therapeutics Training (CT2) Talk | Hojun Li, MD, PhD

Casting a Single Cell Net for Myeloid Leukemia Regulators Using Human Hematopoietic Aging Hojun trained in the M.D./Ph.D. program at the University of Pennsylvania, performing his graduate thesis with Kathy High developing the first method for in vivo genome editing. He did Pediatrics Residency at Boston Children’s Hospital and Hematology/Oncology Fellowship at Dana-Farber Cancer Institute. Following clinical training Hojun was a postdoctoral fellow with Harvey Lodish at the Whitehead Institute elucidating the mechanism of enhanced red cell production by steroids, and then established his independent lab at the MIT Koch Institute as the Charles W.(1955) and Jennifer C. Johnson Clinical Investigator, followed by a move to San Diego in 2024 when he was recruited by the Department of Pediatrics. He has been an American Society of Hematology Scholar, March of Dimes Basil O’Connor Award Scholar, Hartwell Individual Biomedical Research Awardee, Diamond-Blackfan Anemia Foundation Matthew Vroman Memorial Awardee, Hyundai Hope on Wheels Hope Scholar, a Department of Defense Career Development Independent Fellow, and an NIH K08 awardee and Stephen I. Katz Early Stage Investigator Innovative Research Project R01 awardee.